The in vivo tumor-suppressive efficacy of C/M@Alb NCs was evaluated against highly aggressive and metastatic orthotopic E0771 murine breast tumor, which invaded the lung tissue habitually with high mortality rate. The gene discussed is ALB; the disease is breast neoplasm.